Co-diagnoses of acute myeloid leukaemia and COVID-19: presentation and management implications.
Amy O'BrienJames CamplingHugh GoodmanCatherina L ChangPublished in: Respirology case reports (2020)
We report a case of concurrent new diagnoses of confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and acute myeloid leukaemia (AML). We review the existing literature on coronavirus disease 2019 (COVID-19) in the immunocompromised patient and the implications for managing our patient's haematological neoplasm. The implications of severe immunocompromise are unclear in the context of infection with SARS-CoV-2. Respiratory and viral systemic symptoms remained mild in this patient and this is consistent with the existing literature on COVID-19 in immunocompromised patients. To our knowledge, this is the first description of a case of SARS-CoV-2 infection with AML.
Keyphrases
- respiratory syndrome coronavirus
- sars cov
- coronavirus disease
- acute myeloid leukemia
- respiratory failure
- case report
- liver failure
- systematic review
- end stage renal disease
- bone marrow
- drug induced
- healthcare
- ejection fraction
- chronic kidney disease
- dendritic cells
- newly diagnosed
- allogeneic hematopoietic stem cell transplantation
- squamous cell carcinoma
- early onset
- prognostic factors
- low grade
- aortic dissection
- depressive symptoms
- peritoneal dialysis
- radiation therapy
- mechanical ventilation
- locally advanced
- intensive care unit